Home > NRC Library > ADAMS Public Documents

06-28799-01 591459 Alexion Pharmaceuticals, Inc.

Accession Number: ML16203A224

Date Released: Thursday, October 27, 2016

Package Contents

The following links on this page are to Adobe Portable Document Format (PDF) files. To obtain a free viewer for displaying this format, see our Plugins, Viewers, and Other Tools.

• ML16203A228 - Alexion Pharmaceuticals, Inc.; Amendment Request Letter dtd July 12, 2016. (35 page(s), 7/12/2016)
• ML16208A535 - Alexion Pharmaceuticals, Inc., E-mail dated 07/25/2016, Subject: Request for Additional Information Concerning Application for a License Amendment, Control 591459. (2 page(s), 7/25/2016)
• ML16279A318 - Alexion Pharmaceuticals, Inc.; Telephone Conversation Record dtd 10/3/2016, RE: Deficiency Request due to Response to E-mail dated July 25, 2016; Control No. 591459. (1 page(s), 10/3/2016)
• ML16292A762 - Alexion Pharmaceuticals, Inc., License Amendment, Mail Control No. 591459. (3 page(s), 10/5/2016)
• ML16293A057 - Alexion Pharmaceuticals, Inc.; Amendment No. 18, Mail Control No. 591459. (3 page(s), 10/5/2016)